Category: Health News
Utah Woman Files Cook Celect® IVC Filter Lawsuit
Cook Medical has been sued by a woman who was injured by a blood clot filter that is associated with high rates of perforation through a major vein where it is implanted to prevent pulmonary embolisms.
Atrium C-QUR Mesh Recall Lawsuits Centralized in New Hampshire
Three years after Atrium recalled thousands of C-QUR Hernia Mesh implants because the fish oil coating could peel off, nearly two dozen injury lawsuits were centralized in a federal court in New Hampshire. Lawyers say the mesh causes inflammation, allergic...
Missouri Woman Files Cook Günther Tulip® IVC Filter Lawsuit
A woman who was injured by a blood clot-catching filter made by Cook Medical has filed a lawsuit accusing the company of selling a defective medical device.
EPA Panel to Investigate Cancer Risk with Monsanto’s Roundup
The Environmental Protection Agency (EPA) is holding a three-day series of meetings this week dedicated to examining evidence linking Monsanto’s Roundup weedkiller to cancer.
Ethicon Recalls Physiomesh Hernia Mesh in Europe, Australia
Ethicon is facing several lawsuits from people who were injured by Physiomesh hernia mesh. It was pulled off the market in the United States after studies found higher rates of hernia recurrence and revision surgery. The FDA did not announce...
Alzheimer’s Cure Within Reach After Successful Drug Trial
A drug that ‘switches off’ production of toxic proteins caused by Alzheimer’s disease is raising hopes that a cure could finally be within reach.
Texas Woman Files Cook Celect® Platinum Lawsuit
A woman who was injured by a "new-and-improved" version of an IVC filter that has been linked to serious risks has filed a lawsuit against Cook Medical.
Vaccine Worries Rise As Mumps Outbreaks Hit 10-Year Peak
Mumps outbreaks are spreading across the U.S. at their fastest rate in a decade — mostly in fully-vaccinated students. As new viruses emerge, so have concerns that the 50 year-old mumps vaccine may not work as well as Merck claims.
Bristol-Myers Squibb to Pay $19.5 Million Over Improper Marketing of Abilify
Bristol-Myers Squibb has agreed to pay $19.5 million to resolve allegations that the company made misleading representations to promote its blockbuster antipsychotic drug Abilify (generic: aripiprazole).